Wall Street stocks waver after robust US data puts brake on interest rate cut bets – Go Health Pro

Wall Street stocks waver after robust US data puts brake on interest rate cut bets – Go Health Pro

Stay informed with free updates Simply sign up to the US equities myFT Digest — delivered directly to your inbox. Big technology stocks led a decline on Wall Street on Monday as long-term Treasury yields hit the highest level since late 2023 after last week’s strong US jobs data led traders to further slash expectations … Read more

North Korea’s hypersonic missile test puts US, and Trump, on notice – Go Health Pro

North Korea’s hypersonic missile test puts US, and Trump, on notice – Go Health Pro

North Korea says it test-fired a hypersonic intermediate-range ballistic missile on Monday, in a provocative display of its advancing weapons capabilities timed to coincide with a visit by Washington’s top diplomat to the region that came just days before the inauguration of US president-elect Donald Trump. State media heralded the test as a major milestone. … Read more

Allstate puts Milton loss at $102m, suggesting cat bond at-risk. YTD pre-tax losses hit $4.84bn – Go Health Pro

Allstate puts Milton loss at 2m, suggesting cat bond at-risk. YTD pre-tax losses hit .84bn – Go Health Pro

US insurer Allstate has confirmed its pre-tax loss from hurricane Milton at $102 million, at which level it seems possible the Sanders Re II Ltd. (Series 2024-2) catastrophe bond may face a loss, while the companies year-to-date pre-tax catastrophe losses have reached $4.84 billion after October.Previously, Allstate had reported an initial estimate for its hurricane … Read more

Zacks Small Cap Research – SNGX: Marburg Outbreak Puts Focus on Soligenix Vaccine Development… – Go Health Pro

Zacks Small Cap Research – SNGX: Marburg Outbreak Puts Focus on Soligenix Vaccine Development… – Go Health Pro

By David Bautz, PhD NASDAQ:SNGX READ THE FULL SNGX RESEARCH REPORT Business Update Marburg Virus Outbreak Puts Focus on Soligenix Vaccine Development Soligenix, Inc. (NASDAQ:SNGX) is developing vaccines targeting multiple filoviruses, including MarVax, a heat stable vaccine for protection against Marburg virus. Recent events highlight the importance of the company’s vaccine development program. On October … Read more

x